Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
107 Leser
Artikel bewerten:
(0)

Elevate Clinical Research Solutions Announces Launch of "Train and Build" Service Line and Webinar Series

Finanznachrichten News

Empowering Clinical Research Sites Through Tailored Training and Expertise

MADISON, WISCONSIN / ACCESS Newswire / January 22, 2025 / Elevate Clinical Research Solutions is proud to announce the launch of its latest service line, "Train and Build", designed to address the pressing operational challenges faced by clinical research sites. Alongside this initiative, Elevate is hosting a Train & Build Webinar Series, a five-part program aimed at empowering research professionals with actionable insights and expert guidance. The series kicked off on November 20, 2024, with additional sessions continuing through early 2025.

The "Train and Build" service line provides tailored support for clinical research sites, focusing on comprehensive training and process development. The program offers site-customized solutions for enhancing internal expertise in critical areas, including coverage analysis, budget management, and contract negotiation. By strengthening in-house teams and incorporating best practices, "Train and Build" equips sites to navigate complex clinical trials with greater efficiency and confidence.

"Our new service line is a natural extension of our mission to support clinical research sites with innovative, hands-on solutions," said Nicole Bruecker, Senior Director of Elevate Clinical Research Solutions. "'Train and Build' reflects our commitment to helping sites not only manage current challenges but also build sustainable capabilities for the future."

The Train & Build Webinar Series complements this service, providing an interactive platform for education and engagement. The series began with the session "Empower Your Site's Budgeting Process with Site-Specific Training and Support" on November 20, hosted by Senior Director Nicole Bruecker. This session focused on common budgeting challenges, offering practical strategies and actionable insights to enhance site operations.

"Through the Train & Build initiative, we aim to share our expertise and foster meaningful collaborations with research sites," said Nicole Bruecker. "These webinars are an opportunity for attendees to engage directly with our team, address their unique challenges, and take their site operations to the next level."

The second session, "Advancing Coverage Analysis Expertise", will take place on January 29, 2025, and will also be led by Nicole Bruecker. This webinar will delve into coverage analysis challenges, providing personalized advice and practical solutions to help sites navigate this complex area. Future sessions in the series will further explore the operational intricacies of clinical research start-up services, including team building and industry best practices.

To register for the upcoming webinar, visit the Train & Build Webinar Registration Page.

About Elevate Clinical Research Solutions

At Elevate Clinical Research Solutions we understand the challenges of clinical research sites and offer customized solutions to help offload workload, navigate through research complexities, mitigate risks, and reduce costs and start-up timelines. We are experienced in coverage analysis, budget development and negotiations, contract redline and negotiations, revenue protection, CTMS builds, train and build, and research team staffing. In an industry where costs are rising and personal touch is lost, we are committed to providing quality services working as an extension of your research team.

For more information on Elevate Clinical Research Solutions, visit www.elevatecrs.com

Contact Information

Katie Kovar
Marketing Director
kkovar@elevatecoding.com
3145800045

.

SOURCE: Elevate Clinical Research Solutions



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.